Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Reimbursement In Brief

This article was originally published in The Gray Sheet

Executive Summary

Planning for P4P: CMS should leverage early commercial market pay-for-performance experience as it implements value-based hospital payments in FY 2009, an Agency for Healthcare Research & Quality-funded study in the Nov. 2 New England Journal of Medicine says. A survey of 242 HMOs revealed that in 2005 52% used pay-for-performance incentives in provider contracts. The authors note that programs were more prevalent when plan enrollees were required to select a primary care physician, an aspect not shared by Medicare, and physician rewards for quality care were generally greater than 5%, which may not be financially feasible for Medicare's program. Meanwhile, CMS' final hospital outpatient 1rule, released Nov. 1, expands quality measures hospitals must report to receive full inpatient payment increases in FY 2008. New pay-for-reporting measures include patient satisfaction and mortality outcomes. CMS postpones tying outpatient payments to quality reporting until 2009 to develop appropriate measures...

You may also be interested in...



Last-Minute Legislative Package Includes R&D Credit, Medicare Fixes

Congress was poised late last week to pass a legislative package extending a number of tax, trade and health provisions set to expire by year-end, but the bill fails to address some specific device industry priorities

Last-Minute Legislative Package Includes R&D Credit, Medicare Fixes

Congress was poised late last week to pass a legislative package extending a number of tax, trade and health provisions set to expire by year-end, but the bill fails to address some specific device industry priorities

Ambulatory Payment Classification Meeting In Brief

No floor for payment drops: APC advisory panel will not recommend that CMS limit payment decreases in its 2007 outpatient rule as the agency has in past years. In 2006, median costs for device-dependent APCs could not decline more than 10% from the previous year (1"The Gray Sheet" Aug. 14, 2006, p. 4). The Medical Device Manufacturers Association told the panel Aug. 24 in Baltimore, Md., that large drops in payment "perpetuate unpredictability in reimbursement and will lead to limited patient access to high-technology devices and procedures." According to CMS' proposed rule, released Aug. 8, only six APCs will see declines of more than 10% in median costs in 2007. "These devices were artificially inflated through the pass-through [payments]," suggested agency staffer Anita Heygster. She said that the reduced payments may simply reflect the appropriate relative estimated costs for the procedures...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT024170

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel